Amarantus Bioscience Holdings Inc (AMBS)

[breezy1]

So if we get a status update on MANF and b - cells, and we have a large Pharma to engage AMBS at this point, or just the research. How much is that worth? Well I would think the shares would trade in the 1Billion market cap area for starters, we are at 45million now.
So what about 20 times higher or .80 or .90 cents. Under a buck. But if a large pharma indicated to support co-development marketing, it would push it much much higher. Aug Last year:
" We have found that MANF can protect and stimulate proliferation of b -cells in a mouse model of type 1 diabetes. In addition, we generated mice which lack MANF protein, resulting in development of T1D. Since MANF has direct effects of mouse b -cells and is expressed and regulated in human b - cells we hope that MANF has therapeutic potential for the treatment of T1D, where b -cell protecting and regenerating therapies are not available" says Professor Mart Saarma.